Farther Finance Advisors, LLC

Position in MRNA — Moderna, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in MRNA

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$1,080,492

+$53,774 QoQ

Shares Held

15,429

-23.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#287

of 772 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. MRNA ranks #2 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc. This page	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,080,492	15,429	-23.7%	Shares	Sole	2026-07-17
2026-03-31	$1,026,718	20,211	+335.4%	Shares	Sole	2026-04-07
2025-12-31	$136,892	4,642	+0.7%	Shares	Sole	2026-01-23
2025-09-30	$119,024	4,608	-3.7%	Shares	Sole	2025-10-14
2025-06-30	$131,962	4,783	+34.9%	Shares	Sole	2025-07-11
2025-03-31	$100,500	3,545	+0.7%	Shares	Sole	2025-04-14
2024-12-31	$146,320	3,519	+289.3%	Shares	Sole	2025-02-10
2024-09-30	$60,414	904	-16.5%	Shares	Sole	2024-10-29
2024-06-30	$128,487	1,082	+33.4%	Shares	Sole	2024-07-31
2024-03-31	$86,420	811	+33.4%	Shares	Sole	2024-05-14
2023-12-31	$60,465	608	+147.2%	Shares	Sole	2024-02-15
2023-09-30	$25,409	246	+75.7%	Shares	Sole	2023-11-14
2023-06-30	$17,010	140	+22.8%	Shares	Sole	2024-05-14
2023-03-31	$17,508	114	-26.5%	Shares	Sole	2024-05-14
2022-12-31	$27,841	155	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.